Skip to main content

Table 5 Summary of evidence-based cancer therapy by MSC as deduced by the meta-analysis of peer-reviewed experimental/ preclinical research studies

From: Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review

MSC

MSC GM status #

Tumor target

Effect on tumor target

Evidence in support

AT

Modified (or naïve)

Neural

Suppression

**

UC

Naïve (or modified)

Breast

Suppression

***

UC

Modified (or naïve)

Lung

Suppression

**

BM

Modified

Neural

Suppression

**

BM

Modified

Lung

Suppression

**

BM

Modified (or naïve)

Pancreas

Suppression

*

BM

Naïve

Breast

Promotion

***

BM

Naïve

Osteosarcoma

Promotion

*

  1. # Primary or secondary/minor (in brackets) contribution of the genetic modification status of the MSC to the overall observed effect on tumor target
  2. No. of studies *≥ 3, **≥ 6, ***≥ 10